PureTech Announces the Appointment of Michele Holcomb, PhD, to the Board of Directors
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, recently announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb’s appointment will take effect as of September 23, 2024. She brings more […]
STEMCELL Technologies to acquire all assets of SQZ Biotechnologies Company
STEMCELL Technologies announced the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders today, marks another significant milestone for STEMCELL, Canada’s […]
Aptar designates Julie Xing to its board of directors
AptarGroup, Inc. a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced recently that Julie Xing has joined its Board of Directors. With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in […]
Bayer AG appoints Bill Anderson to CEO
The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimously after a thorough selection process which began mid last year. Werner Baumann (60), current CEO […]
IntoCell signs MTA with ADC Therapeutics
IntoCell recently announced the signing of a Material Transfer Agreement (MTA) with option to license with ADC Therapeutics SA Under the agreement, IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, will provide proprietary drug-linkers developed using their proprietary Ortho-Hydroxy Protected Aryl Sulfate (OHPASTM) system and payload modification technology (PMT). ADC […]
XNK Therapeutics onboards Dr. Anna-Karin Maltais as CSO
XNK Therapeutics AB (“XNK”) recently announced the appointment of Dr. Anna-Karin Maltais as Chief Scientific Officer (CSO), effective October 17th. She will be a member of the company’s management team. Anna-Karin Maltais, PhD, will be responsible for further developing and implementing XNK Therapeutics’ scientific strategy. She will lead a team responsible for research and innovation with focus on […]
Azzur Group announces cGxP and Bioprocessing training program
US based Azzur Training Center announces the release of a comprehensive training course catalog spanning current good manufacturing practices (cGMP), regulatory requirements, industry manufacturing skills, and quality systems. Azzur Training Center, an Azzur Group company, specializes in bioprocessing concepts that allow life science innovators to start, scale, and sustain their cGMP organizations. Azzur works hand-in-hand with one of the world’s top pharmaceutical, […]
MetaVentures Summit in Bangkok to be held in December 1-3
The international summit MetaVentures Bangkok will be held on December 1-3, 2022. MetaVentures – presents its second unique event in Thailand. The exclusivity of the event opens the door to business and investment opportunities targeting a broad international audience. Investments, Blockchain, Metaverse and NFT, Biotech, DeFi, DAO, Digital Art, mining, payment systems and digital asset […]
